| 前收盘价格 | 1.97 |
| 收盘价格 | 2.00 |
| 成交量 | 5,251,000 |
| 平均成交量 (3个月) | 10,004,887 |
| 市值 | 4,256,868,608 |
| 市盈率 (P/E TTM) | 28.57 |
| 价格/销量 (P/S) | 2.88 |
| 股市价格/股市净资产 (P/B) | 0.940 |
| 52周波幅 | |
| 利润日期 | 30 Mar 2026 |
| 营业毛利率 | 8.42% |
| 营业利益率 (TTM) | 11.23% |
| 稀释每股收益 (EPS TTM) | 0.070 |
| 季度收入增长率 (YOY) | -0.80% |
| 季度盈利增长率 (YOY) | 11,430.90% |
| 总债务/股东权益 (D/E MRQ) | 33.65% |
| 流动比率 (MRQ) | 1.67 |
| 营业现金流 (OCF TTM) | 373.99 M |
| 杠杆自由现金流 (LFCF TTM) | 188.26 M |
| 资产报酬率 (ROA TTM) | 1.98% |
| 股东权益报酬率 (ROE TTM) | 5.92% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (HK) | 混合的 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | VIVA BIOTECH | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -2.0 |
| 平均 | -1.63 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| VIVA BIOTECH | 4 B | - | 28.57 | 0.940 |
| CSTONE PHARMA-B | 14 B | - | - | 27.87 |
| CKLIFE SCIENCES | 7 B | - | - | 1.88 |
| ANTENGENE-B | 3 B | - | - | 2.84 |
| SINOMAB BIO-B | 2 B | - | - | 4.23 |
| IMMUNOTECH-B | 2 B | - | - | 20.15 |
|
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 43.29% |
| 机构持股比例 | 7.84% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合